These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17312249)

  • 1. Progress in governance of converging technologies integrated from the nanoscale.
    Roco MC
    Ann N Y Acad Sci; 2006 Dec; 1093():1-23. PubMed ID: 17312249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Framework for assessing governance of the health system in developing countries: gateway to good governance.
    Siddiqi S; Masud TI; Nishtar S; Peters DH; Sabri B; Bile KM; Jama MA
    Health Policy; 2009 Apr; 90(1):13-25. PubMed ID: 18838188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converging technologies and human destiny.
    Bainbridge WS
    J Med Philos; 2007; 32(3):197-216. PubMed ID: 17613702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.
    Kimbrell GA
    J Law Med Ethics; 2009; 37(4):706-23. PubMed ID: 20122111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Governance strategies for living technologies: bridging the gap between stimulating and regulating technoscience.
    van Est R; Stemerding D
    Artif Life; 2013; 19(3-4):437-50. PubMed ID: 23834596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnologies, bioethics and human dignity.
    Visciano S
    J Int Bioethique; 2011; 22(1):17-36, 206. PubMed ID: 21850967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outlining ethical issues in nanotechnologies.
    Spagnolo AG; Daloiso V
    Bioethics; 2009 Sep; 23(7):394-402. PubMed ID: 19673855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating small things: genes, gametes and nanotechnology.
    Bennett B
    J Law Med; 2007 Aug; 15(1):153-60. PubMed ID: 17902497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The social, moral, ethical, legal and political implications of today's biological technologies: an Indian point of view.
    Bhargava PM
    Biotechnol J; 2006 Jan; 1(1):34-46. PubMed ID: 16892223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation: threat to converging technologies.
    Ziegler AS
    Ann N Y Acad Sci; 2006 Dec; 1093():339-49. PubMed ID: 17312267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology and the human future: policy, ethics, and risk.
    Cameron NM
    Ann N Y Acad Sci; 2006 Dec; 1093():280-300. PubMed ID: 17312264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converging technologies in higher education: paradigm for the "new" liberal arts?
    Balmer RT
    Ann N Y Acad Sci; 2006 Dec; 1093():74-83. PubMed ID: 17312252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leadership, governance and management in dental education - new societal challenges.
    Townsend G; Thomas R; Skinner V; Bissell V; Cohen L; Cowpe J; Giuliani M; Gomez-Roman G; Hovland E; Imtiaz A; Kalkwarf K; Kim KK; Lamster I; Marley J; Mattsson L; Paganelli C; Quintao C; Swift J; Thirawat J; Williams J; Soekanto S; Jones M
    Eur J Dent Educ; 2008 Feb; 12 Suppl 1():131-48. PubMed ID: 18289276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underwhelmed: hyperbole, regulatory policy, and the genetic revolution.
    Caulfield T
    McGill Law J; 2000 May; 45(2):437-60. PubMed ID: 12688281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology: the coming revolution and its implications for consumers, clinicians, and informatics.
    Staggers N; McCasky T; Brazelton N; Kennedy R
    Nurs Outlook; 2008; 56(5):268-74. PubMed ID: 18922283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnology and the birth of a third culture.
    Binetti P
    J Biol Regul Homeost Agents; 2004; 18(3-4):255-60. PubMed ID: 15786691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The United States Department of Energy's Regional Carbon Sequestration Partnerships Program Validation Phase.
    Litynski JT; Plasynski S; McIlvried HG; Mahoney C; Srivastava RD
    Environ Int; 2008 Jan; 34(1):127-38. PubMed ID: 17950875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early identification and assessment of new and emerging health technologies: actions, progress, and the future direction of an international collaboration--EuroScan.
    Simpson S; Packer C; Carlsson P; Sanders JM; Ibarluzea IG; Fay AF; Norderhaug I
    Int J Technol Assess Health Care; 2008; 24(4):518-25. PubMed ID: 18828949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.